PURPOSE: This retrospective case series study aimed to document eyecare practitioners' (ECPs') real-world experience using Vyzulta (latanoprostene bunod; LB), including satisfaction, utilization patterns, and patient (pt) outcomes. This interim sub-analysis reports ECP satisfaction and utilization patterns.

METHODS: This sub-analysis of a retrospective, multicenter, cross-sectional study includes survey responses from ≥30 ECPs from Brazil, Canada, Hong Kong, Mexico, South Africa, South Korea, Taiwan, Thailand, Tunisia, Turkey, Ukraine, the UAE, and the USA. ECPs were currently licensed optometrists or ophthalmologists with ≥3 years' experience treating pts, and who had prescribed LB on-label (reduction of intraocular pressure in pts with open-angle glaucoma or ocular hypertension) to ≥10 pts in the last 12 months. ECPs completed a retrospective user-experience survey about their experience with LB. Key outcomes included clinical practice setting, LB utilization patterns, and ECP satisfaction with LB.

RESULTS: TBD – To be updated by February 2026

CONCLUSIONS: TBD – To be updated by February 2026